4.7 Review

Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting

Journal

NEUROLOGY
Volume 90, Issue 2, Pages 74-82

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000004798

Keywords

-

Funding

  1. Fight MSA

Ask authors/readers for more resources

Multiple system atrophy (MSA) is a rare neurodegenerative disorder with substantial knowledge gaps despite recent gains in basic and clinical research. In order to make further advances, concerted international collaboration is vital. In 2014, an international meeting involving leaders in the field and MSA advocacy groups was convened in Las Vegas, Nevada, to identify critical research areas where consensus and progress was needed to improve understanding, diagnosis, and treatment of the disease. Eight topic areas were defined: pathogenesis, preclinical modeling, target identification, endophenotyping, clinical measures, imaging biomarkers, nonimaging biomarkers, treatments/trial designs, and patient advocacy. For each topic area, an expert served as a working group chair and each working group developed priority-ranked research recommendations with associated timelines and pathways to reach the intended goals. In this report, each groups' recommendations are provided.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Distribution Patterns of Astrocyte Populations in the Human Cortex

Shelley L. Forrest, Jordan Hanxi Kim, Daniel R. Crockford, Katharine Huynh, Rosie Cheong, Samantha Knott, Madison A. Kane, Lars M. Ittner, Glenda M. Halliday, Jillian J. Kril

Summary: This study maps the distribution and density of astrocytes in the human frontal cortex, revealing distinct and overlapping populations of astrocytes. The findings provide a reference map for comparative studies in various disease and injury states involving astrocytes.

NEUROCHEMICAL RESEARCH (2023)

Review Geriatrics & Gerontology

Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders

Krista L. Lanctot, Zahinoor Ismail, Kritleen K. Bawa, Jeffrey L. Cummings, Masud Husain, Moyra E. Mortby, Philippe Robert

Summary: This narrative review discusses the clinical features of apathy and depression in individuals with neurocognitive disorders, aiming to differentiate the two syndromes based on clinical presentation, diagnostic criteria, neuropathological features, and response to treatments.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

Single-cell DNA methylation sequencing by combinatorial indexing and enzymatic DNA methylation conversion

Zac Chatterton, Praves Lamichhane, Diba Ahmadi Rastegar, Lauren Fitzpatrick, Helene Lebhar, Christopher Marquis, Glenda Halliday, John B. Kwok

Summary: This study presents a single-cell DNA methylation sequencing method that can accurately resolve the DNA methylation profiles of individual cells. The sciEM method improves sequencing alignment rates, reduces adapter contamination, and over-estimation of DNA methylation levels. The researchers successfully applied this method to resolve single-cell DNA methylation of major cell types in the human brain.

CELL AND BIOSCIENCE (2023)

Article Neuroimaging

Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum br

Nga Yan Tse, Martina Bocchetta, Emily G. Todd, Emma M. Devenney, Sicong Tu, Jashelle Caga, John R. Hodges, Glenda M. Halliday, Muireann Irish, Matthew C. Kiernan, Olivier Piguet, Jonathan D. Rohrer, Rebekah M. Ahmed

Summary: Through studying a large sample of 211 participants, it was found that different subregions of the hypothalamus are correlated with cognitive and behavioral impairments. Patients with ALS, mixed ALS-FTD, and bvFTD all showed hypothalamic involvement. Cognitive and behavioral symptoms were correlated with bilateral involvement of the anterior inferior, anterior superior, and posterior hypothalamic subregions. The anterior superior and superior tuberal subregions displayed the greatest volume loss in bvFTD and ALS-FTD, and ALS, respectively, and were associated with specific neuropeptide expression abnormalities.

NEUROIMAGE-CLINICAL (2023)

Article Biochemistry & Molecular Biology

Development of a Novel Electrochemiluminescence ELISA for Quantification of ?-Synuclein Phosphorylated at Ser129 in Biological Samples

Suman Dutta, Simon Hornung, Hash Brown Taha, Karl Biggs, Ibrar Siddique, Lea M. Chamoun, Hedieh Shahpasand-Kroner, Carter Lantz, Marcos Herrera-Vaquero, Nadia Stefanova, Joseph A. Loo, Gal Bitan

Summary: A new method for sensitive detection of pS129-alpha-syn has been developed, which can be applied to various biological samples. This method provides a valuable tool for discovering and monitoring neurodegenerative diseases associated with abnormal accumulation of synaptic proteins.

ACS CHEMICAL NEUROSCIENCE (2023)

Review Psychology, Clinical

Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm

Jeffrey Cummings, Mary Sano, Stefanie Auer, Sverre Bergh, Corinne E. Fischer, Debby Gerritsen, George Grossberg, Zahinoor Ismail, Krista Lanctot, Maria I. Lapid, Jacobo Mintzer, Rebecca Palm, Paul B. Rosenberg, Michael Splaine, Kate Zhong, Carolyn W. Zhu

Summary: The IPA Agitation Work Group develops an algorithm for reducing and preventing agitation, which emphasizes the integration of psychosocial and pharmacologic interventions, reiterative assessment of response to treatment, adjustment of therapeutic approaches, and shared decision-making. The algorithm includes different treatment choices for different levels of agitation.

INTERNATIONAL PSYCHOGERIATRICS (2023)

Article Clinical Neurology

GRK2-Targeted Knockdown as Therapy for Multiple System Atrophy

Miguel Lopez-Cuina, Paul Guerin, Nathalie Dutheil, Christelle Martin, Thierry Leste Lasserre, Pierre-Olivier Fernagut, Wassilios G. Meissner, Erwan Bezard

Summary: This study demonstrates that lowering brain GRK2 levels through delivery of a GRK2-specific miRNA can reverse central nervous system insulin resistance and provide neuroprotection in a mouse model of multiple system atrophy. These findings suggest that GRK2 may be a potential therapeutic target for the treatment of MSA.

MOVEMENT DISORDERS (2023)

Review Cell Biology

Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy

Jen-Hsiang T. Hsiao, Onur Tanglay, Anne A. Li, Aysha Y. G. Strobbe, Woojin Scott Kim, Glenda M. Halliday, YuHong Fu

Summary: Multiple system atrophy (MSA) is a debilitating movement disorder with unknown etiology. It presents with characteristic parkinsonism and/or cerebellar dysfunction due to deterioration in specific brain regions. The early pathological events and development mechanisms of MSA are reviewed, focusing on the involvement of oligodendrocyte lineage cells and alpha-synuclein. This understanding will guide future research in MSA.

CELLS (2023)

Review Biochemistry & Molecular Biology

Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders

Ramakrishna Nirogi, Pradeep Jayarajan, Anil Shinde, Abdul Rasheed Mohammed, Venkata Ramalingayya Grandhi, Vijay Benade, Vinod Kumar Goyal, Renny Abraham, Venkat Jasti, Jeffrey Cummings

Summary: Serotonin-6 (5-HT6) receptor, a G-protein-coupled receptor, plays a key role in the regulation of various functions in the nervous system. Clinical studies have shown that 5-HT6 receptor antagonists have potential in treating cognitive deficits associated with Alzheimer's disease (AD) and neuropsychiatric symptoms in dementia. However, the outcomes of phase 3 trials for these antagonists have been disappointing. Masupirdine, a selective 5-HT6 receptor antagonist, has shown promise in reducing agitation/aggression-like behaviors in animal models and may have potential benefits for agitation and psychosis in AD, but further trials are needed.

BIOMOLECULES (2023)

Article Clinical Neurology

UMSARS Versus Laryngoscopy-Based Assessment of Dysphagia

Nadia El Fassi, Anne Pavy le Traon, Emmanuelle Mouchon, Olivier Rascol, Wassilios G. G. Meissner, Alexandra Foubert-Saumier, Yohan Gallois, Samuel Tessier, Fabienne Ory-Magne, Virginie A. A. Woisard, Margherita Fabbri

Summary: The study compared the assessment of dysphagia in MSA patients using UMSARS and an ENT expert assessment, and found that UMSARS does not fully capture pharyngo-laryngeal dysfunction.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Real-life ankle submovements and computer mouse use reflect patient-reported function in adult ataxias

Nicole M. Eklund, Jessey Ouillon, Vineet Pandey, Christopher D. Stephen, Jeremy D. Schmahmann, Jeremy Edgerton, Krzysztof Z. Gajos, Anoopum S. Gupta

Summary: This study tested the use of wearable sensors and a computer mouse task as reliable and meaningful motor measures for potential use in clinical trials. The results showed that these measures were strongly correlated with patient function and ataxia rating scales, indicating their potential as sensitive motor outcome measures.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric study

Ana Marques, Elise Macias, Bruno Pereira, Elodie Durand, Carine Chassain, Tiphaine Vidal, Luc Defebvre, Nicolas Carriere, Valerie Fraix, Elena Moro, Stephane Thobois, Elise Metereau, Graziella Mangone, Marie Vidailhet, Jean-Christophe Corvol, Stephane Lehericy, Nicolas Menjot de Champfleur, Christian Geny, Umberto Spampinato, Wassilios G. Meissner, Solene Frismand, Emmanuelle Schmitt, Anne Doe de Maindreville, Christophe Portefaix, Philippe Remy, Gilles Fenelon, Jean Luc Houeto, Olivier Colin, Olivier Rascol, Patrice Peran, Jean-Marie Bonny, Maria Livia Fantini, Franck Durif

Summary: This study evaluated brain volumetric changes in PD patients using MRI and found that baseline brain volumetric characteristics may predict clinical trajectories at 1 year. Specifically, posterior cingulate cortex atrophy was associated with motor decline, while amygdala and hippocampus atrophy were associated with psycho-behavioral decline.

JOURNAL OF NEUROLOGY (2023)

Letter Clinical Neurology

The importance of patient-centred drug development for amyotrophic lateral sclerosis

Matthew C. Kiernan, Glenda M. Halliday, Dominic B. Rowe, Rachel H. Tan

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Neuroimaging

Parkinson's disease progression: Increasing expression of an invariant common core subnetwork

Phoebe G. Spetsieris, David Eidelberg

Summary: Notable progress has been made in the study of neurodegenerative diseases using reduction techniques such as principal component analysis (PCA) and sparse inverse covariance estimation (SICE) in positron emission tomography (PET) data. In a recent study on Parkinson's disease (PD) patients, SICE combined with PCA was used to optimize maps of functional metabolic connectivity and identify key regional hubs and their connections in the brain. This approach revealed a core subnetwork that remained consistent across PD patients and could serve as a target for disease modification.

NEUROIMAGE-CLINICAL (2023)

Review Neurosciences

Ferdinando Rossi Lecture: the Cerebellar Cognitive Affective Syndrome-Implications and Future Directions

Jeremy D. Schmahmann

Summary: The cerebellum plays a role in cognition and emotion, in addition to motor control. Clinical observations and studies have shown its connectivity with various brain areas involved in autonomic control, sensorimotor integration, vestibular function, and emotions. Understanding the cerebellum's involvement in cognition and emotion is crucial for studying higher order deficits and neuropsychiatric disorders related to cerebellar diseases.

CEREBELLUM (2023)

No Data Available